Multiple Sclerosis Discovery Forum

Inspiring Connections

Sort By: Most Recent Article / Most Recent Comments / Most Comments

News Briefs | 23 Mar 2014

MS Research Roundup: March 21, 2014

Tests of HIV Drug in Progress for RRMS; Statin Discovery in Progressive MS; Bench-to-Bedside MS Research Talks Online

Carol Cruzan Morton

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Meetings

News Briefs | 20 Mar 2014

Atacicept Phase 2 Trial Yields Disappointing Results for MS

Atacicept, which targets B cells, increased rather than decreased exacerbations in relapsing MS

Steven Fox

Results from a phase 2 trial of the recombinant fusion protein atacicept raise significant questions about...

Clinical Research, Drug Development

News Briefs | 11 Mar 2014

Complementary/Alternative Medicine Use Changes With MS Progression

The transition from moderate to severe impairment is when many MS patients turn to complementary or alternative medicine

Laurie Barclay, M.D.

Persons with MS use complementary and alternative medicine most often during...

Clinical Research

News Briefs | 4 Mar 2014

Fatigue in MS Linked to Elevated Body Temperature

This cross-sectional study has revealed that elevated body temperature is associated with fatigue in relapsing-remitting multiple sclerosis, even in the absence of heat exposure

Steven Fox

Elevated body temperature is associated with fatigue in patients with relapsing-remitting multiple sclerosis...

Clinical Research

News Briefs | 4 Mar 2014

MS Research Roundup: March 4, 2014

Evidence-Based MS Care: New Systematic Reviews and Protocols for Mycophenolate Mofetil, Cognitive Rehabilitation, Alemtuzumab vs. Interferon β-1a; Call for Reviewers

Carol Cruzan Morton

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research

News Briefs | 3 Mar 2014

MS Progression More Closely Linked to Atrophy of Gray Matter Than White Matter

Gray matter atrophy seen on MRI showed better association with MS progression than did white matter atrophy at 5 and 10 years, although atrophy occurred in whole brain, cortex, and putamen

Laurie Barclay, M.D.

Gray matter atrophy seen on MRI showed better association with multiple sclerosis disease progression than did...

Clinical Research

News Briefs | 3 Mar 2014

IL-1β Levels During MS Remission May Predict Progression

A study of 170 patients with relapsing-remitting MS found that detectable levels of IL-1β in cerebrospinal fluid may help predict disease progression

Steven Fox

Detection of interleukin-1β in cerebrospinal fluid during periods of remission appears to be a...

Clinical Research

News Briefs | 26 Feb 2014

MS Research Roundup: February 26, 2014

Potassium Channel Preview; Modern Treatment Overview; How to Succeed in Science; MSers at FoxNews

Carol Cruzan Morton

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, People

News Briefs | 20 Feb 2014

MS Research Roundup: February 20, 2014

NICE Isn’t Nice to Tecfidera; Best-Selling MS Drugs; So Many Papers, So Little Time; Lessons From Stroke

Carol Cruzan Morton

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Laboratory Research

News Briefs | 19 Feb 2014

Obstructive Sleep Apnea Contributes to MS Fatigue

Diagnosing and treating OSA may eliminate 11% to 40% of the fatigue attributed to MS

Ricki Lewis, Ph.D.

Some of the fatigue that affects up to 90% of people with MS may be due to...

Clinical Research, Drug Development